Therapie

Article	Citations
Uses of pharmacovigilance databases: An overview	90
“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers	87
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection	70
Safety data and withdrawal of hepatotoxic drugs	53
Addictovigilance contribution during COVID-19 epidemic and lockdown in France	51
Pharmacovigilance and drug safety: Fair prescribing and clinical research	48
Drug repositioning for rare diseases: Knowledge-based success stories	41
Polypharmacy: A general review of definitions, descriptions and determinants	37
Drug repurposing in rare diseases: Myths and reality	35
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence	33
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)	30
Efficacy of COVID-19 vaccines: From clinical trials to real life	29
Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations	26
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres	25
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge	23
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy	21
Diabetes and COVID-19	21
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France	20
Prolonged-release buprenorphine formulations: Perspectives for clinical practice	19
Chloroquine and hydroxychloroquine during pregnancy: What do we know?	19
Orphan drug clinical development	18
Self-medication practices and their characteristics among French university students	17
Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19	15
COVID-19 and NSAIDs: Primum non nocere	14
Genital tract and reproductive characteristics in daughters of women and men prenatally exposed to diethylstilbestrol (DES)	13

Update on bradykinin-mediated angioedema in 2020	12
COVID-19 vaccines: A perspective from social pharmacology	12
Thrombotic events after AstraZeneca vaccine: What if it was related to dysfunctional immune response?	11
Innovative approaches in CNS drug discovery	11
Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review	10
Orphan drug designation in Europe: A booster for the research and development of drugs in rare diseases	10
Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials	10
Epidemiology and economic burden of “serious” adverse drug reactions: Real-world evidence research based on pharmacovigilance data	10
NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection	9
Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database	9
Efficacy of metformin on glycemic control and weight in drug-naive type 2 diabetes mellitus patients: A systematic review and meta-analysis of placebo-controlled randomized trials	9
Warning on increased serious health complications related to non-medical use of nitrous oxide	9
Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature	9
Alteration of the pharmacokinetics of aminoglycosides by adsorption in a filter during continuous renal replacement therapy. An in vitro assessment	9
A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy	8
Incretin-based drugs and intestinal obstruction: A pharmacovigilance study	8
La pharmacogénétique au service du soin en France : une discipline qui évolue !	8
Is the drug a scientific, social or political object?	8
Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19	8
Place of patient-reported outcomes & experiences measurements (PROMS/PREMS) in the assessment and pricing of Health technologies in France	8
Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021	8
Vaccines and Bell's palsy: A narrative review	8
Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemic	7
Calcium channel blocker exposure and psoriasis risk: Pharmacovigilance investigation and literature data	7
Le mésusage du fentanyl en France : 2010 à 2015	7
Drugs acting on renin angiotensin system and use in ill patients with COVID-19	7
Drug-induced meningitis: A review of the literature and comparison with an historical cohort of viral meningitis cases	7
Consommation de substances chez les jeunes : du médicament aux substances illicites	7
Doping with aromatase inhibitors and oestrogen receptor modulators in steroid users: Analysis of a forum to identify dosages, durations and adverse drug reactions	7
Pharmacovigilance and drug-induced rare diseases: Strengths of the French Network of Regional Pharmacovigilance Centres	7
A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19	6
Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol	6
Atteintes musculaires et levure de riz rouge : analyse des données de la base nationale de pharmacovigilance et revue de la littérature	6
Skin cancers under Janus kinase inhibitors: A World Health Organization drug safety database analysis	6
Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database	6
Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data	6
Penetration rate of anti-TNF biosimilars and savings at 5 years after their introduction in French hospitals	6
The challenges of pharmacoepidemiology of orphan drugs in rare diseases	6
COVID-19 vaccines and pregnancy: What do we know?	6
Global research output in ‘pharmacovigilance’ during 2010–2020	5
Synthèse des recommandations de l’International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) sur le suivi thérapeutique pharmacologique du tacrolimus	5
Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19	5
The French pharmacovigilance surveys: A French distinctiveness, a real input	5
Connaissances et attitudes des médecins généralistes à l’égard des effets indésirables des inhibiteurs de la pompe à protons	5
Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic	5
Les politiques de partage de données des financeurs d’essais cliniques en France	5
Profils d’effets indésirables sous abiratérone et enzalutamide : analyse descriptive des données de la base nationale de pharmacovigilance	5
Analyse des seringues usagées : un reflet de la consommation de substances psychoactives par les usagers de drogues par voie intraveineuse ?	5
The need to shed light on potential insidious SARS-CoV-2 post-vaccination pituitary lesions	5
Are β-lactam concentrations adequate in severe sepsis and septic shock in children?	5

Central diabetes insipidus revealing a hypophysitis induced by SARS-CoV-2 vaccine	5
Les médicaments potentiellement inappropriés : adaptation de la liste EU(7)PIM à la pratique médicale française	4
Statin-associated myasthenia: A case report and literature review	4
Chronic spontaneous urticaria following vaccination against SARS-CoV-2	4
Association of UGT2B7 and CaMK4 with response of valproic acid in Chinese children with epilepsy	4
Patients’ organizations in rare diseases and involvement in drug information: Illustrations with LMC France, the French Association of Chronic Myeloid leukemia	4
The drugs that mostly frequently induce gynecomastia: A national case – noncase study	4
Drug consumption during prolonged lockdown due to Covid-19 as observed in French addiction center	4
Pharmacologie du cannabidiol : points de vigilance, conséquences et risques chez l’homme	4
An old drug for a rare disease: The example of celiprolol for vascular Ehlers-Danlos syndrome	4
Platform trials	4
Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series	4
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects	4
Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance study	4
Quality of evidence of the efficacy of therapeutic interventions on patient-important outcomes in Cochrane's systematic reviews’ abstracts: A survey	4
Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice	4
Adherence after treatment switch from a multiple tablet antiretroviral regimen to a single tablet antiretroviral regimen	4
Is caspofungin efficient to treat invasive candidiasis requiring continuous veno-venous hemofiltration? A case report	4
Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives	3
Suivi thérapeutique pharmacologique de la clozapine	3
Pharmaciens d’officine, étudiants en pharmacie et demandes de médicaments à base de codéine : étude observationnelle	3
DPP-4 inhibitors and severe course of illness in patients with COVID-19	3
Enhancing the role played by clinical pharmacists in psychiatric settings to better integrate clinical psychopharmacology into the decision-making process	3
Urticaire sévère avec récidive compliquée d’angiœdème sous sécukinumab : à propos d’un cas	3
Minors and young adult's hospitalizations after “chimique” consumption in Mayotte Island: Which substances are involved?	3
Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses’ infections	3
A historical cohort study to investigation of statins safety in COVID-19 hospitalized patients	3
Severe bone pain with teriflunomide: Five case reports and review of the French pharmacovigilance database	3
Sex differences: From preclinical pharmacology to clinical pharmacology	3
Déclaration des erreurs médicamenteuses dans les recherches portant sur le médicament : place du pharmacien des essais cliniques ?	3
Relapsing generalized bullous fixed drug eruption: A severe and avoidable cutaneous drug reaction. Three case reports	3
Raising public awareness about the misuse of predatory journals: One year after the “hydroxychloroquine and push-scooters accidents” hoax	3
Immunotherapies in acute leukemia	3
Refractory non-variceal upper gastrointestinal bleeding in a liver-transplant patient: Everolimus withdrawal should be considered	3
Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®	3
Interactions médicamenteuses avec la colchicine, les contre-indications sont-elles bien respectées ? Étude descriptive des prescriptions en Bretagne à partir des données de l’Assurance maladie	3
Cinderella side effect: Intravenous corticosteroid-induced bradycardia	3
Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022	3
Green tea and hepatoxicity: Two case reports	3
Les solutions numériques en santé, quelles valeurs apportées, quels mécanismes de financement et quelles évaluations ?	3
Consommer du CBD ou conduire, faut-il choisir ?	3
Non-medical use of baclofen: A case series and review of the literature	3
Use of triptans during pregnancy? With caution!	3
Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)	3
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective	3
Pharmacokinetics of ceftolozane/tazobactam continuous infusion on renal replacement therapy: A pediatric case report	3
A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)	3
Trente ans d’abus de néfopam en France	3
Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic	3
Pharmacotherapy of substance use disorders in the neuroscience-based nomenclature (NbN)	3
Meningiomas after cyproterone acetate exposure: Case reports in twin sisters	3
DRESS syndrome with cholecystitis in a child: A case report and literature review	3
Prescription errors by emergency physicians for inpatients are associated with emergency department length of stay	3
Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic	3
Androgens, QT, sex and ventricular repolarization–a double-edged sword: A case series	3
The “old” cytotoxic drugs, the basis of anti-cancer treatments	3
Bacterial infections in people who inject psychoactive substances: An observational study in a French university hospital	3
Suivi thérapeutique pharmacologique de l’olanzapine	3
Towards personalized pharmacology: Antipsychotics and schizophrenia	3
Évaluation du potentiel d’abus et de dépendance de la quétiapine (Xeroquel®)	3
Daily practices regarding safety monitoring of low-dose methotrexate and comparison to guidelines: A population-based cohort study	3
Complications infectieuses liées à l’utilisation du propofol : une nouvelle série de cas et revue de la littérature	2
Myocardial infarction in relation to colchicine poisoning: A precipitating cause of refractory toxic cardiogenic shock	2
A methodological framework for drug development in rare diseases. The CRESim program: Epilogue and perspectives	2
Hypoglycémie sévère et arrêt cardiorespiratoire attribués au tramadol – à propos d’un cas	2
Leukocytoclastic vasculitis mimicking photosensitivity induced by thiamazole	2
Utilisation et gestion des inhibiteurs de la pompe à protons : une étude observationnelle	2
Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey	2
Balneotherapy in spondyloarthropathy: A systematic review	2
Acute myocarditis during carboplatin and pemetrexed chemotherapy for lung adenocarcinoma	2
The discovery of hypoglycaemic sulphonamides – Montpellier, 1942	2
Efficacy and safety of neural stem cell therapy for spinal cord injury: A systematic literature review	2
Interaction entre amoxicilline/acide clavulanique et fluindione : à propos de deux cas	2
Référentiel ECRIN pour la conformité aux bonnes pratiques de gestion des données des essais cliniques multinationaux	2
Évolution des comportements de consommation de produits psychoactifs illicites ou détournés de leur usage médicamenteux chez les femmes enceintes en France : analyse des données OPPIDUM de 2005 à 2018	2
Spiderweb-like pattern: A novel dermoscopic feature in photo-onycholysis induced by doxycycline?	2
Un tour d’horizon du développement de biomarqueurs pour les anticorps PD-1 et PD-L1 en cancérologie	2
Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France	2
A case of iatrogenic vitamin D toxicity revealed by drug reconciliation	2
Contributions of animal models of cognitive disorders to neuropsychopharmacology	2

Imagerie TEP pour l’étude des répercussions fonctionnelles de la P-glycoprotéine en neuropharmacocinétique	2
No arguments for extra risk from ibuprofen in SARS-COV2 infection	2
Hypophosphatémie et fer injectable : à propos d’un cas et revue de la littérature	2
Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study	2
Severe serotonin syndrome caused by an interaction between an antidepressant and a cough syrup	2
Letrozole induced visual hallucination	2
Étude observationnelle des déclarations de liens d’intérêts au Congrès de la médecine générale France et liens d’intérêts des médecins intervenants	2
Pourquoi et comment améliorer l’information des patients et de leurs aidants au bon usage de leurs dispositifs médicaux tout au long du parcours de soin ?	2
Adverse drug reaction monitoring: Doing it the French way – Act II	2
Poids atropinique et médicaments anticholinergiques : intérêt et application en pratique clinique chez la personne âgée	2
Pharmacokinetics and therapeutic drug monitoring of anticancer protein/kinase inhibitors	2
Un exemple de réorganisation dans le fonctionnement d’un Centre d’investigations cliniques en période de confinement national suite à la pandémie COVID-19	2
Health crisis: What opportunities for clinical drug research?	2
Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted	2
Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemic	2
Hospitalisations après consommation de substances psychoactives pendant la pandémie de COVID-19	2
Olmesartan-associated enteropathy: Belgian survey	2
The 2019 Global Initiative for Asthma report: Evidence-based or evidence-biased medicine?	2
Ambulatory drug changes in the elderly after hospital discharge: A cohort study	2
Innovative approaches in CNS clinical drug development: Quantitative systems pharmacology	2
Usages de substances de synthèse en France et en Europe	2
Project rebuild the evidence base (REB): A method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients	2
Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss – An observational study using the EFEMERIS database	2
Pulmonary hemorrhage in a neonate born to a woman with cystic fibrosis treated with targeted cystic fibrosis transmembrane conductance regulator modulator elexacaftor–tezacaftor–ivacaftor during pregn	2
Impact of diabetes mellitus on rifampicin's plasma concentration and bioavailability in patients with tuberculosis: A systematic review and meta-analysis study	2
Bismuth encephalopathy and mineral waters: a new hypothesis on bismuth absorption	2
Cluster headache after COVID-19 vaccination with Comirnaty: A signal in pharmacovigilance database	2
Modifications pharmacocinétiques liées à une infection aiguë. Exemples issus de la pandémie de SARS-CoV-2	2
Les essais plateformes	2
Case report: Confirming a diagnosis of severe olmesartan-associated enteropathy	2
Syndrome coronarien aigu associé au dronabinol	2
Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in France	2
Delayed thrombocytopenia following administration of abciximab: Pharmacovigilance survey and literature review	2
Buprénorphine d’action prolongée : quelles perspectives pour la pratique clinique ?	2
An atypical Ramsey Hunt syndrome after covid 19 immunization	2
Trends in use of benzodiazepines and Z-drugs in France from 2012 to 2020	1
Experience and expectations of pharmacogenetic tests in France	1
Place des mesures rapportées par les patients (PROMS/PREMS) dans l’évaluation et la valorisation des technologies de santé en France	1
Do drugs interact together in cardiovascular prevention? A meta-analysis of powerful or factorial randomized controlled trials	1
Complications bactériennes chez les usagers de drogues par injection	1
La naloxone sauve des vies : qu’en pensent les usagers ?	1
Épisodes d’agitation et d’hallucinations dans les suites d’une intoxication aux tricycliques : à partir de deux cas cliniques	1
Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020	1
Prescription-free consultation in France and Europe: Rates’ evolution, physicians’ and patients’ perceptions from 2005 to 2019, a systematic review	1
Why and how can we improve patient and caregiver information for the proper use of their medical devices throughout the care pathway?	1
Prise en charge de l’hypersensibilité immédiate aux β-lactamines : étude rétrospective au centre de pharmacovigilance de Sfax	1
Idiopathic non-cirrhotic portal hypertension (INCPH) during azathioprine treatment in patient with Crohn's disease: A case report	1
A bilateral aseptic pyogenic ventriculitis following a course of pembrolizumab, an anti-PD-1 immune checkpoint inhibitor treatment for metastatic small cell lung cancer	1
Lessons from the COVID-19 pandemic	1
Benefit-risk balance of COVID drugs. New prospects	1
Analyse des modifications de statut réglementaire des médicaments en France : 2010–2019	1
Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?	1
Évaluation et impact des pictogrammes « grossesse » apposés sur les conditionnements extérieurs des médicaments : enquête auprès de 281 femmes	1
Medication errors involving opioid maintenance therapy	1
Systematic review on sex differences for drug use after stroke	1
Atypical neurological toxicity attributed to oxaliplatin	1
Pharmacoepidemiology and public decision	1
The relationship between relative telomere length and anti-tuberculosis drug-induced hepatitis : A case-control study	1
Hypertriglycéridémie majeure, découverte sur une pseudohyponatrémie, induite par la l-asparaginase dans le cadre du traitement d’une leucémie aiguë lymphoblastique B pédiatrique	1
Consommation de substances psychoactives illicites par vapotage : les données d’addictovigilance	1
Vinorelbine and carboplatin-induced black tongue: A case report	1
Éléments de l’interprétation et du dialogue clinico-biologique pour le suivi thérapeutique pharmacologique de la vancomycine	1
Management of a delayed acetaminophen exposure after massive overdose: A case study	1
Overview of clinical trials vigilance units in French institutional sponsors – A study from the REVISE working group	1
Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide	1
Pharmacology and pharmacovigilance of protein kinase inhibitors	1
Flu vaccine-induced purpura annularis telangiectodes of Majocchi	1
Évaluation des prescriptions d’anticoagulants oraux directs (AOD) en gériatrie hospitalière sur 3 ans	1
Enquête satisfaction dans le centre d’investigations cliniques (CIC-1427) de l’hôpital Saint-Louis	1
Argatroban et thrombopénie induite par l’héparine : observatoire des modalités de prescription et d’utilisation en France	1
Adverse drug reactions in pregnant women: Do they differ from those in non-pregnant women of childbearing age?	1
Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS): Interest of skin tests in cross-reactivity to phenobarbital	1
Sex differences in adverse drug reactions: Are women more impacted?	1
Pneumopathie médicamenteuse ou liée à la COVID-19 : un train peut en cacher un autre !	1
Autoimmune hepatitis following mRNA COVID-19 vaccine	1
Modification de la perception des sons sous antiépileptiques : une revue de la littérature et des bases de pharmacovigilance	1
Amlodipine and perindopril-induced hypertrichosis in a six-year-old girl: A case report	1
Pheochromocytoma presented by Takotsubo, unmasked by accumulation of paroxetine, in a cytochrome poor metabolizer patient: A case report	1
Continuous assessment of volunteers’ satisfaction in clinical research through simplified questionnaires	1
Le mésusage de la cigarette électronique : une centaine de jeunes hospitalisés après avoir vapoté dans le nord-est de la France	1
Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis	1
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION project	1
Reality of drug-induced erythema multiforme: A French pharmacovigilance study	1
Prévalence des prescriptions des statines chez les personnes âgées des EHPAD de l’Occitanie Ouest	1
Thiamine et trouble de l’usage d’alcool : une enquête de pratique nationale	1
Cutaneous adverse effects of antiepileptic drugs	1
Poudre d’opium et addictovigilance : état des lieux	1
Refractory cardiogenic shock caused by methadone poisoning and treated with hybrid extracorporeal membrane oxygenation	1
Drug-induced cardiac toxicity and adverse drug reactions, a narrative review	1
Balancing the reactogenicity of the ChAdOx1 nCov-19 vaccine against COVID-19 and the urgent need of a large immunization in healthcare workers	1
Drug-related risk of hospital readmission in children with chronic diseases, a systematic review	1
Enquête sur la certification aux bonnes pratiques cliniques en recherche académique	1
Effets indésirables de l’antimoniate de méglumine dans la leishmaniose cutanée chez le sujet âgé	1
Addictovigilance in women, the hidden part of the iceberg?	1
À propos d’un cas d’exacerbation sévère d’acouphènes lors d’un syndrome d’arrêt à la venlafaxine	1